Hudson Bay Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-7,600
Closed -$2.12M 1229
2025
Q2
$2.12M Sell
7,600
-165,600
-96% -$46.9M 0.01% 780
2025
Q1
$54M Buy
+173,200
New +$51.1M 0.17% 122
2019
Q1
Sell
-12,500
Closed -$2.43M 684
2018
Q4
$2.43M Buy
+12,500
New +$2.44M 0.03% 466
2018
Q3
Sell
-39,600
Closed -$7.31M 694
2018
Q2
$7.31M Buy
+39,600
New +$7M 0.1% 190
2018
Q1
Sell
-35,000
Closed -$6.09M 763
2017
Q4
$6.09M Buy
+35,000
New +$6.19M 0.13% 134
2013
Q4
Sell
-200,000
Closed -$22.4M 158
2013
Q3
$22.4M Buy
+200,000
New +$21.7M 0.83% 34

Other funds holding AMGN

Hudson Bay Capital Management's AMGN Position: Q3 2025 in Review

Hudson Bay Capital Management sold out of Amgen (AMGN) in Q3 2025, closing a stake of 8,561 shares — an estimated $2.39M sold.

Hudson Bay Capital Management first reported a position in AMGN in Q1 2018 and held it in 11 quarters. The position peaked at $54.6M in Q4 2022. 2,820 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Hudson Bay Capital Management reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
  • Hudson Bay Capital Management sold 8,561 Amgen shares in Q3 2025, an estimated $2.39M.
  • Hudson Bay Capital Management first reported a position in Amgen in Q1 2018 and held it in 11 quarters.
  • Hudson Bay Capital Management's Amgen position peaked at $54.6M in Q4 2022.
  • 2,820 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Hudson Bay Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.